Publication | Open Access

A 15-Year Follow-up of AJCC Stage III Malignant Melanoma Patients Treated Postsurgically with Newcastle Disease Virus (NDV) Oncolysate and Determination of Alterations in the CD8 T Cell Repertoire

Cancer ImmunosurveillanceMelanomaImmunologyPathology15-Year Follow-upImmunotherapyMedicineViral OncologyTumor MicroenvironmentNewcastle Disease VirusCancer-associated Virus